Invention Grant
- Patent Title: Rapamycin for the treatment of lymphangioleiomyomatosis
-
Application No.: US15028365Application Date: 2014-10-07
-
Publication No.: US10307370B2Publication Date: 2019-06-04
- Inventor: Henri Lichenstein , Jonathan M. Rothberg , Thomas Armer , Lawrence S. Melvin, Jr.
- Applicant: LAM Therapeutics, Inc.
- Applicant Address: US CT Guilford
- Assignee: AI Therapeutics, Inc.
- Current Assignee: AI Therapeutics, Inc.
- Current Assignee Address: US CT Guilford
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Muriel Liberto, Esq.
- International Application: PCT/US2014/059529 WO 20141007
- International Announcement: WO2015/054280 WO 20150416
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/14 ; A61K9/16 ; A61K45/06 ; A61K47/26 ; A61K31/436 ; A61K31/445
Abstract:
The present invention relates to methods and compositions for treating lymphangioleiomyomatosis in a human subject in need of such treatment. The methods comprise administering to the subject via inhalation an aerosol composition comprising rapamycin or a prodrug or derivative (including analog) thereof.
Public/Granted literature
- US20160235668A1 Rapamycin for the Treatment of Lymphangioleiomyomatosis Public/Granted day:2016-08-18
Information query
